MedTrace Logo

The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls

NCT06114342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 184

Last updated 2024-03-15

No results posted yet for this study

Summary

Evidence-based medicine suggests that acupuncture can improve major depressive disorder (MDD). However, the prevalent reliance on experiential acupoint selection lacks scientific underpinning. The investigators conducted a comparative study involving MDD patients and healthy subjects, employing modern techniques to discern biological specificity in MDD-related acupoints. Additionally, the investigators investigated potential correlations between acupoint biological specificity and MDD severity.

Conditions

Sponsors & Collaborators

  • Zhejiang Provincial Tongde Hospital

    collaborator OTHER

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Xiaomei Shao

    lead OTHER

Principal Investigators

  • Xiaomei Shao · The Third Affiliated hospital of Zhejiang Chinese Medical University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06114342 on ClinicalTrials.gov